Nicholas A. Zorko, PhD
University of Minnesota Masonic Cancer Center
Topic Presenter
Biography
Dr. Nicholas Zorko is a physician-scientist at the University of Minnesota Masonic Cancer Center. He completed his MD/PhD training at the Ohio State University and continued his residency and fellowship training in hematology/oncology at the University of Minnesota. His clinical practice focuses on genitourinary malignancies and cellular therapies to treat solid tumors. His translational lab seeks to develop novel natural killer cell immune engagers and engineered effector cells to treat genitourinary malignancies. He is a Prostate Cancer Foundation Young Investigator and is also funded by the Department of Defense to develop novel natural killer cell therapies. He is currently the site principal investigator for industry-sponsored immune engager studies targeting PSMA and B7-H3 offered at the University of Minnesota's Masonic Cancer Center.
Financial Disclosure
Department of Defense Prostate Cancer Research Program
Consultant
Bayer (personal fees), Takeda (pro bono)
Advisor
Association of Community Cancer Centers
Speaker
Bayer (to Institution)
Professional Service
Janux (travel expenses only)
Other
Department of Defense, National Insitutes of Health, Prostate Cancer Foundation
Grant Or Contract
Amgen (institutional)
Contractor
Janssen (institutional)
Contractor
GT Biopharma (institutional)
Contractor
Johnson & Johnson (institutional)
Contractor
Janux Therapeutics (institutional)
Contractor
Takeda (institutional)
Contractor
Lava Therapeutics (institutional)
Contractor
Bayer (travel expenses only)
Other
Janux (Travel expenses only)
Other
Telix (travel expenses only)
Other
Arsenal (institutional)
Contractor